| 1 | | | LC-MS/MS Operations in the Clinical Laboratory (Full Day) |
| Brian Rappold, BS | 07/28/24 | 9-4:30 |
| 2 | | | Solving Problems and Resolving Challenges in Point-of-Care Testing (Full Day) |
| Peggy Mann, MS, MT (ASCP), CPP | 07/28/24 | 9-4:30 |
| 3 | | | Solving Problems and Resolving Challenges in Point-of-Care Testing (Full Day) |
| Jeanne Mumford, BS, MLS (ASCP) | 07/28/24 | 9-4:30 |
| 4 | | | Solving Problems and Resolving Challenges in Point-of-Care Testing (Full Day |
| Kimberly Skala, BA, MT (ASCP) | 07/28/24 | 9-4:30 |
| 5 | | | Solving Problems and Resolving Challenges in Point-of-Care Testing (Full Day |
| Kerstin Halverson, MS | 07/28/24 | 9-4:30 |
| 6 | | | Unlocking the Power of Laboratory Informatics: Integrating New Tests, Optimizing Test Ordering, and Leveraging Data Analytics (Full Day) |
| Anand Dighe, MD, PhD | 07/28/24 | 9-4:30 |
| 7 | | | Next Generation Sequencing for Laboratorians: Understanding the Essentials (Half Day) |
| Christina Lockwood, ABMG, DABCC | 07/28/24 | 9-12 |
| 8 | | | Next Generation Sequencing for Laboratorians: Understanding the Essentials (Half Day) |
| Jillian Buchan, ABMG | 07/28/24 | 9-12 |
| 9 | | | Toxicology Roadmap: Everything You Need to Know About Successfully Running a Urine Drug Testing Service (Half Day) |
| Claire Knezevic, PhD, DABCC | 07/28/24 | 9-12 |
| 10 | | | Navigating Laboratory Errors in the Preanalytical, Analytical, and Postanalytical Phases of Testing (Half Day) |
| Mark Cervinski, PhD, DABCC, FADLM | 07/28/24 | 9-12 |
| 11 | | | Navigating Laboratory Errors in the Preanalytical, Analytical, and Postanalytical Phases of Testing (Half Day) |
| Alison Woodworth, PhD, DABCC, FADLM | 07/28/24 | 9-12 |
| 12 | | | Troubleshooting LC-MS/MS: Identifying Method Problems and Building Robustness (Half Day) |
| Deborah French, PhD, DABCC, FADLM | 07/28/24 | 1:30-4:30 |
| 13 | | | Fundamentals of Method Evaluation and Validation (Half Day) |
| Kornelia Galior, PhD, DABCC | 07/28/24 | 1:30-4:30 |
| 14 | | | 32101 Community Engagement, Research, and Healthcare: Laboratory Medicine’s Lead Role in Ensuring Health Equity |
| Octavia Peck Palmer, PhD, FADLM | 07/29/24 | 10:30-12 |
| 15 | | | 32101 Community Engagement, Research, and Healthcare: Laboratory Medicine’s Lead Role in Ensuring Health Equity |
| Omai Garner, PhD, ABMM, MT (ASCP) | 07/29/24 | 10:30-12 |
| 16 | | | 32102 Bad, Better, Best: Putting Data Visualizations to the Test |
| T. Scott Isbell, PhD, DABCC, FACB | 07/29/24 | 10:30-12 |
| 17 | | | 32102 Bad, Better, Best: Putting Data Visualizations to the Test |
| Christopher McCudden, PhD, DABCC, FACB, FCAC | 07/29/24 | 10:30-12 |
| 18 | | | 32103 Real-Time Mass Spectrometry: Strategies for Rapid Drug and Metabolite Detection to Enhance Clinical Decision Making |
| Dennis Dietzen, PhD, DABCC, FADLM | 07/29/24 | 10:30-12 |
| 19 | | | 32103 Real-Time Mass Spectrometry: Strategies for Rapid Drug and Metabolite Detection to Enhance Clinical Decision Making |
| Stephen Roper, PhD, DABCC, NRCC | 07/29/24 | 10:30-12 |
| 20 | | | 32106 Is Bad Testing Better Than No Testing? |
| Yachana Kataria, PhD, DABCC | 07/29/24 | 10:30-12 |
| 21 | | | 32105 Ethical Decision Making for Laboratory Professionals |
| Ann Gronowski, PhD, DABCC | 08/29/24 | 10:30-12 |
| 22 | | | 32107 Tools for Recognizing and Eliminating Preanalytical Error |
| Christopher Farnsworth, PhD, DABCC | 07/30/24 | 10:30-12 |
| 23 | | | 32109 The Nexus of Innovation: How Laboratory Medicine Supports Cellular and Gene Therapy Advancements |
| Zhen Zhao, PhD, DABCC, FADLM | 07/30/24 | 10:30-12 |
| 24 | | | 33106 Dipping Your Toes Into the Data Analytics Pool: A Session With Laboratory Professionals Working on Informatics Projects |
| Mark Cervinski, PhD, DABCC, FADLM | 07/30/24 | 10:30-12 |
| 25 | | | 33108 Informatics and Technological Approaches for Addressing the Challenges of Large-Scale Genomic Testing: Overcoming the Challenges of Whole Exome Sequencing for the Diagnosis of Patients With Monogenic Kidney Disease |
| Daniela del Gaudio, PhD, DABMGG | 07/30/24 | 10:30-12 |
| 26 | | | 33106 Dipping Your Toes Into the Data Analytics Pool: A Session With Laboratory Professionals Working on Informatics Projects: Developing Machine Learning Models to Improve Test Utilization and Laboratory Stewardship |
| He Yang, PhD, DABCC | 07/30/24 | 10:30-12 |
| 27 | | | 32441 Operationalizing Changes to LDT Oversight: Building Roadmaps When the Rubber Hits the Road |
| Jonathan Genzen, MD, PhD | 07/29/24 | 12:30-2 |
| 28 | | | 32441 Operationalizing Changes to LDT Oversight: Building Roadmaps When the Rubber Hits the Road |
| Stephen Master, MD, PhD, FADLM | 07/29/24 | 12:30-2 |
| 29 | | | 32442 Unexpected Results: Using Proficiency Testing to Improve Toxicology and Pharmacogenetic Testing in Your Lab |
| Christine Snozek, PhD, DABCC, FADLM | 07/29/24 | 12:30-2 |
| 30 | | | 32442 Unexpected Results: Using Proficiency Testing to Improve Toxicology and Pharmacogenetic Testing in Your Lab |
| Gwendolyn McMillin, PhD, DABCC | 07/29/24 | 12:30-2 |
| 31 | | | 32443 Moving Beyond Sensitivity and Specificity: Showing the Value of Lab Medicine Through Outcome Measures |
| David Grenache, PhD, DABCC, MT (ASCP) | 07/29/24 | 12:30-2 |
| 32 | | | 32443 Moving Beyond Sensitivity and Specificity: Showing the Value of Lab Medicine Through Outcome Measures |
| Zhen Zhao, PhD, DABCC, FADLM | 05/07/24 | 12:30-2 |
| 33 | | | 32445 Pathogen Detection, Machine Learning, or Host Biomarkers: Can Any of These Technologies Help Address the Challenge of Sepsis? |
| Alison Woodworth, PhD, DABCC, FADLM | 07/29/24 | 12:30-2 |
| 34 | | | 32446 Automating Digital Workflows in the Clinical Laboratory Using Robotic Process Automation |
| Daniel Holmes | 07/29/24 | 12-2:30 |
| 35 | | | 32221 Responding to the Threat of Xylazine and Drug Supply Adulteration: Clinical Testing Strategies and Empowering Point-of-Service Community Drug Checking |
| Adina Badea, PhD, DABCC | 07/29/24 | 2:30-4 |
| 36 | | | 32222 Emerging Diagnostics to Differentiate Type I from Type II Myocardial Infarction and Acute Non-Ischemic Myocardial Injury |
| Alan Wu, PhD, DABCC | 07/29/24 | 2:30-4 |
| 37 | | | 32222 Emerging Diagnostics to Differentiate Type 1 From Type 2 Myocardial Infarction and Acute Non-Ischemic Myocardial Injury |
| Xander van Wijk, PhD, DABCC, FADLM | 07/29/24 | 2:30-4 |
| 38 | | | 32223 Navigating Challenges in Tumor Marker Testing: Insights and Solutions |
| Jonathan Genzen, MD, PhD | 07/29/24 | 2:30-4 |
| 39 | | | 32223 Navigating Challenges in Tumor Marker Testing: Insights and Solutions |
| J Shirley Li, PhD, MD, DABCC, NRCC | 07/29/24 | 2:30-4 |
| 40 | | | 32225 Operationalizing AI in Lab Medicine: Approaches for Effective Machine Learning Integration and Deployment |
| Thomas Durant, MD | 07/29/24 | 2:30-4 |
| 41 | | | 32226 Improving Lead Testing Access: Leaning Into Decision Support Tools and Lead Screening by Dried-Blood Spots |
| Jessica Colon-Franco, PhD, DABCC, FADLM | 07/29/24 | 2:30-4 |
| 42 | | | 33101 ADLM Healthcare Forum: The Impact of LDT Oversight on the Delivery of Care |
| Joe Wiencek, PhD, DABCC, NRCC, FADLM | 07/30/24 | 10:30-12 |
| 43 | | | 33101 ADLM Healthcare Forum: The Impact of LDT Oversight on the Delivery of Care |
| Dennis Dietzen, PhD, DABCC, FADLM | 07/30/24 | 10:30-12 |
| 44 | | | 33104 Clinical Chemistry Journal Hot Topics: A Point-Counterpoint on LDL-C Equations |
| Ian Young, MD | 07/30/24 | 10:30-12 |
| 45 | | | 33107 Capital Purchases and Cost Accounting for Lab Leaders: Essential Skills for Demonstrating the Value of the Laboratory |
| Zachary Zaret, MHA, DLM(ASCP)CM | 07/30/24 | 10:30-12 |
| 46 | | | 33108 Informatics and Technological Approaches for Addressing the Challenges of Large-Scale Genomic Testing |
| Kai Lee Yap, PhD, DABMGG | 07/30/24 | 10:30-12 |
| 47 | | | 33105 Improv and the Art of Medicine: Adaptable Skills for an Uncertain World: Developing Machine Learning Models to Improve Test Utilization and Laboratory Stewardship |
| He Yang, PhD, DABCC | 07/30/24 | 10:30-12 |
| 48 | | | 33222 Course Correction: A Chemistry Compliance Compilation |
| Grace Williams, PhD, DABCC | 07/30/24 | 2:30-4 |
| 49 | | | 33226 Getting Started with Data Analytics: Indirect Reference Intervals as a Case Study |
| Kelly Doyle, PhD, DABCC, FADLM | 07/30/24 | 2:30-4 |
| 50 | | | 33226 Getting Started with Data Analytics: Indirect Reference Intervals as a Case Study |
| Daniel Holmes,MD | 07/30/24 | 2:30-4 |
| 51 | | | 33228 Microbes Meet Machines: Total Laboratory Automation in Clinical Microbiology |
| Caitlin Otto, PhD | 07/30/24 | 2:30-4 |
| 52 | | | 33229 Navigating Constitutional Genomic Disorders Throughout the Exome |
| Joel Lefferts, PhD, DABCC, ABB | 07/30/24 | 2:30-4 |
| 53 | | | 34105 Clinical Toxicology in the Courtroom: How to Serve as an Expert Witness |
| Alan Wu, PhD | 07/31/24 | 10:30-12 |
| 54 | | | 34108 Point-of-Care Testing Challenges in Traditional and Non-Traditional Settings |
| Nichole Korpi-Steiner, PhD, DABCC | 07/31/24 | 10:30-12 |
| 55 | | | 34101 International Regulatory Considerations for Laboratory-Developed Tests: Opportunities and Risks for Patient Care: Impact of Diagnostic Regulations on Laboratory-Developed Tests in the United States |
| Christina Lockwood, PhD, DABMGG, DABCC | 07/31/24 | 10:30-12 |
| 56 | | | 34107 JALM Hot Topics: Current Challenges and Future Promise in Molecular Diagnostics: Genomic Data Optimization: Cost-Effective Utilization and Future Opportunities in Germline Sequencing for Enhanced Patient Care and Diagnostic Resolution |
| Ann Moyer, MD, PhD | 07/31/24 | 10:30-12 |
| 57 | | | 34226 Academy Conversations Between Clinical Laboratorians and Clinicians: Ideal Laboratory Report of Cervical Cancer Detection and Calculation of CIN3+ Risk |
| Yusheng Zhu, PhD, DABCC | 07/31/24 | 2:30-4 |
| 58 | | | 34224 Confronting a New Wave of Opioid Overdoses Through Surveillance Testing: Public Health Initiatives, Wastewater Epidemiology, and Comprehensive Drug Checking Analysis |
| Adina Badea, PhD, DABCC | 07/31/24 | 2:30-4 |
| 59 | | | 34228 Current and Future State of Metagenomics for Infectious Diseases Testing |
| Esther Babady, PhD, D(ABMM), FIDSA | 07/31/24 | 2:30-4 |
| 60 | | | 34225 Adventures in Clinical Decision Support: Interactive Cases in Laboratory Stewardship: Stop the Bleeding: CDS Solutions for Peripheral Smear Review Requests |
| Joseph Rudolf, MD | 07/31/24 | 2:30-4 |
| 61 | | | 35101 Effective Communication with C-Suite Executives: A Chief of Operations and a Department Chair Perspective |
| Victoria Zhang, PhD, MBA, DABCC, FADLM | 08/01/24 | 10:30-12 |
| 62 | | | 35103 Primer on Regulatory Aspects of In Vitro Diagnostics: How to Make Sense of the Alphabet Soup |
| William Clarke, PhD, MBA, DABCC, FADLM | 08/01/24 | 10:30-12 |
| 63 | | | 35103 Primer on Regulatory Aspects of In Vitro Diagnostics: How to Make Sense of the Alphabet Soup |
| Stephen Master, MD, PhD, FADLM | 08/01/24 | 10:30-12 |
| 64 | | | 35106 A Pathway Towards Greater Sustainability in Lab Medicine |
| Joe Wiencek, PhD, DABCC, NRCC, FADLM | 08/01/24 | 10:30-12 |
| 65 | | | 42102/52202 Preanalytical Factors in Blood Gas Analysis |
| Xander van Wijk, PhD, DABCC, FADLM | 07/29/24 | 7:30-8:30 and 12:30-1:30 |
| 66 | | | 42116/52216 Laboratory Assessment of Acquired Thrombocytopenia |
| Olajumoke Oladipo, MD, MSc, DABCC, FADLM | 07/29/24 | 7:30-8:30 & 12:30-1:30 |
| 67 | | | 42118/52218 Ensuring Quality Measurements of Emerging and Traditional Biomarkers for Cardiovascular Diseases: The CDC Cardiovascular Disease Biomarker Standardization Programs |
| Alicia Lyle, PhD, FAHA | 07/29/24 | 7:30-8:30 & 12:30-1:30 |
| 68 | | | 42121/52221 Implementing a New Test or a New Instrument? A Crash Course on Method Validation |
| Kornelia Galior, PhD, DABCC, FADLM | 07/29/24 | 7:30-8:30 & 12:30-1:30 |
| 69 | | | 42122/52222 Laboratory Stewardship: Tests Pending at Discharge |
| Andrew Fletcher, MD, MBA. CPE, CHCQM | 07/29/24 | 7:30-8:30 & 12:30-1:30 |
| 70 | | | 42123/52223 Improving the Timeliness of Test Results: A Symphony of Process, TAT, and Quality! |
| Vrajesh Pandya, PhD, DABCC | 07/29/24 | 7:30-8:30 & 12:30-1:3 |
| 71 | | | 43101/53201 The Cardiopulmonary Bypass Adjustment at the Point-of-Care Measurement of Hematocrit and Hemoglobin: When to Use and When Not To? |
| Mustafa Barbhuiya, PhD | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 72 | | | 43102/53202 Party of 1 at the Point-of-Care Table? Add a Seatmate! |
| Peggy Mann, MS, MT (ASCP), CPP | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 73 | | | 43103/53203 Point-of-Care Testing: Figuring Out How Many Point-of-Care Staff Are Needed |
| Kathleen David, BA, ASCP, MT (ASCP) | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 74 | | | 43108/53208 Practical Guidance for Evaluating and Selecting Automated Chemistry Analyzers to Implement in Academic Clinical Laboratories |
| Stefani Thomas, PhD, DABCC, NRCC | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 75 | | | 43109/53209 Assay Interference: Tracking Analytical Difficulties in a Central Automated Lab Setting |
| Ruhan Wei, PhD, DABCC, NRCC | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 76 | | | 43110/53210 Standardization and Integration of Chemistry Laboratories Across the Health System |
| Melissa Ulas, MD, PhD, NRCC, SCYM(ASCP) | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 77 | | | 43111/53211 Diagnostic Blood Loss: Why It Is of Concern and How to Minimize It |
| Saptarshi Mandal, MD, MS | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 78 | | | 43112/53212 Laboratory Lament: Cracking the Code on Clinical Workforce Woes |
| Marc Rumpler, PhD, ASCP, DABCC, NRCC, FADLM | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 79 | | | 43113/53213 Lab Injuries and Exposures: The Real Data |
| Dan Scungio, MLS (ASCP), SLS, CQA (ASQ) | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 80 | | | 43119/53219 Considerations of HbA1c Measurement |
| Shu-Ling Fan, PhD, DABCC, FADLM | 07/30/24 | 7:30-8:30 & 12:30-1:3 |
| 81 | | | 44101/54201 Delta Check Performance Assessment by Using Real-World Data and Receiver Operating Characteristic Curves |
| Melissa Ulas, MD, PhD, NRCC, SCYM(ASCP) | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 82 | | | 44110/54210 Optimizing Laboratory Medicine Through Strategic Planning |
| Mahesheema Ali, PhD, NRCC, FADLM | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 83 | | | 44112/54212 Standardizing Vitamin D Tests: Progress and Challenges Observed by the CDC Clinical Standardization Programs |
| Otoe Sugahara, BS | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 84 | | | 44114/54214 I Know I Should Use a Reference Material, but How? |
| Karen Phinney, PhD | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 85 | | | 44115/54215 How Blood Tests Are Affected by Transfusion or Apheresis |
| Saptarshi Mandal, MD, MS | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 86 | | | 44118/54218 Implementing Best Practices for CYP2D6 Pharmacogenetic Testing |
| James Canner, PhD | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 87 | | | 44119/54219 Heparin-Induced Thrombocytopenia Testing, Method Selections, and Need of Confirmatory Testing |
| Mustafa Barbhuiya, PhD | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 88 | | | 44125/54225 Recent Developments in Improving Pediatric Reference Intervals |
| Li Zha, PhD, DABCC, NRCC | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 89 | | | 44126/54226 Newborn Screening and Follow-up for Metabolic Disorders |
| Uttam Garg, PhD, DABCC, NRCC, FABFT, FADLM | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 90 | | | 44127/54227 Advancing Thyroid Function Testing Through the CDC Standardization Programs: Improving Accuracy and Reliability of Measurements |
| Uliana Danilenko, PhD | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 91 | | | 44110/54210 Optimizing Laboratory Medicine Through Strategic Planning |
| Mahesheema Ali, PhD, NRCC, FADLM | 07/31/24 | 7:30-8:30 & 12:30-1:3 |
| 92 | | | LDT Special Session
How FDA oversight of LDTs will affect patient care: A conversation with ADLM, the American Medical Association, the Children’s Hospital Association, and a patient advocate |
| Octavia Peck Palmer, PhD, FADLM | 07/30/24 | 4:30-6:00 |
| 93 | | | LDT Special Session How FDA oversight of LDTs will affect patient care: A conversation with ADLM, the American Medical Association, the Children’s Hospital Association, and a patient advocate |
| Dennis Dietzen, PhD, DABCC, FADLM | 07/30/24 | 4:30-6:00 |
| 94 | | | Embracing New Quality Specifications: Adjusting Lab Practices - CLIA 2024 and Beyond |
| James H. Nichols, PhD, DABCC, FADLM | 07/31/24 | 7-8:30 |
| 95 | | | Embracing New Quality Specifications: Adjusting Lab Practices - CLIA 2024 and Beyond |
| Lorin Bachmann, PhD, DABCC | 07/31/24 | 7-8:30 |
| 96 | | | Embracing New Quality Specifications: Adjusting Lab Practices - CLIA 2024 and Beyond |
| John Yundt-Pacheco, MSCS | 07/31/24 | 7-8:30 |